Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
about
Retrospective comparison of three doses of metronomic chlorambucil for tolerability and efficacy in dogs with spontaneous cancer.Celecoxib decreases growth and angiogenesis and promotes apoptosis in a tumor cell line resistant to chemotherapyMetastatic primary duodenal adeno-carcinoma responding to metronomic oral cyclophosphamide chemotherapyLow-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine.TLR agonists: our best frenemy in cancer immunotherapyCombination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Metronomic chemotherapy for cancer treatment: a decade of clinical studies.Metronomics: towards personalized chemotherapy?A systematic literature analysis of correlative studies in low-dose metronomic chemotherapy trials.Current achievements and future perspectives of metronomic chemotherapy.Safety and therapeutic effect of metronomic chemotherapy with cyclophosphamide and celecoxib in advanced breast cancer patients.Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostateReply: Metronomic chemotherapy with cyclophosphamide and dexamethasone in patients with metastatic carcinoma of the prostate.Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophosphamide and celecoxib: clinical outcomes and biomarkers of response.Continuous, low-dose capecitabine for patients with recurrent colorectal cancer.Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients
P2860
Q33431916-32EDD217-8F2A-433E-8856-63398337D12AQ33913432-33C466A3-F1A6-46BD-8105-A37A005024B3Q34131391-4B51FB07-D6C3-4167-BBEE-93E42C3D65C7Q36527473-097499B5-15F1-4D78-847D-9F51A31988A1Q36850457-AD456B5A-7654-4AF1-8C9D-D5C81D41F909Q37086200-99A3652D-0D54-4E5E-8FD5-6E1000AEE052Q38087885-BFC2EC76-DC1D-4750-B2B1-98B08CB41A8DQ38218923-D6246319-3287-463D-852A-5C532F447B74Q38249998-09346F4E-4EC6-446A-837E-C77F23C6B8BAQ38788234-1BBB7A00-9D92-41B2-AD56-1AE371EE3BA5Q39455513-EF3B0D7D-DC4F-4FCD-94FB-9870A616B448Q42545841-DC785D8F-C383-4D07-9AC9-A7D4ED06B0C9Q46231184-B3BD7919-5F05-414A-B025-AF7F4513E467Q53223630-547E39D7-0FB8-4F98-9373-0CD7BA28361FQ53630314-0CD55180-FCE6-4044-89AF-EA258C35E9BFQ57495758-8BA7E6D6-4CF0-4ADB-85B6-7285EA5C7C6D
P2860
Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Continuous low-dose cyclophosp ...... patients with advanced cancer
@ast
Continuous low-dose cyclophosp ...... patients with advanced cancer
@en
type
label
Continuous low-dose cyclophosp ...... patients with advanced cancer
@ast
Continuous low-dose cyclophosp ...... patients with advanced cancer
@en
prefLabel
Continuous low-dose cyclophosp ...... patients with advanced cancer
@ast
Continuous low-dose cyclophosp ...... patients with advanced cancer
@en
P2093
P2860
P356
P1476
Continuous low-dose cyclophosp ...... patients with advanced cancer
@en
P2093
A L Harris
A S Protheroe
D C Talbot
M R Middleton
P2860
P2888
P304
P356
10.1038/BJC.2011.154
P407
P577
2011-05-17T00:00:00Z